TapImmune Inc. is a public OTC-BB biotechnology company with its core business focus on emerging technologies based on cellular immunology and genetic understanding of the cause and potential novel treatments of disease.

Corporate Governance

Financial Statements

Fiscal Year 2011
Form 10-QSB 2011 Q1 Report
Fiscal Year 2010
Form 10-KSB 2010 Annual Report
Click here for a list of all previous filings
		Corporate Snapshot